Retrospective analysis and strategy of platelet transfusion for 17 patients with RhD incompatible platelet transfusion
-
摘要: 目的 通过回顾性分析RhD血型不相合血小板输注的患者，总结RhD不相合血小板输注的经验和应对策略。方法 利用医院六级电子病历和临床输血管理系统，获取2014至2021年血型为RhD阴性且符合研究纳入标准的17例患者，收集其基本信息、检验结果、血液输注的情况并进行统计分析。结果 17例患者ABO血型A型、B型、O型、AB型占比分别为2例(11.76%)、5例(29.41%)、9例(52.94%)、1例(5.88%)；输注血小板总计51个治疗量，其中2个治疗量为RhD阴性，49个治疗量为RhD阳性；输注血小板后随访时间为28~167 d；均未见输血不良反应；不规则抗体筛查结果阴性，未见RhD及其他同种免疫反应。结论 RhD血型不相合血小板输注可有效改善患者出血及凝血相关指标，且不会引起严重的输血不良反应及免疫反应，为血小板减少症和出血患者带来益处，保障临床血小板治疗的及时性和有效性。Abstract: Objective To summarize the experience and coping strategies of RhD incompatible platelet transfusion by retrospectively analyzing the cases of RhD incompatible platelet transfusion.Methods A total of 17 cases with RhD negative blood type from 2014 to 2021 and meeting the inclusion criteria of the study were obtained by using the level 6 electronic medical record and clinical blood transfusion management system of our hospital, and the basic information, test results and blood transfusion of patients were collected and statistically analyzed.Results Seventeen cases of platelet transfusion with incompatible RhD blood group were obtained, and the proportion of ABO type A, B, O and AB was 2(11.76%), 5(29.41%), 9(52.94%) and 1(5.88%), respectively. A total of 51 treatment volumes were transfused, of which 2 were RhD negative and 49 were RhD positive. The follow-up time after platelet transfusion was 28-167 days. No adverse reaction of blood transfusion was observed. Irregular antibody screening results were negative, and no RhD or other alloimmune responses were observed.Conclusion Platelet transfusion with incompatible RhD blood group could effectively improve the bleeding and coagulation related indicators of patients, and would not cause serious adverse blood transfusion reactions and immune reactions, bring benefits to patients with thrombocytopenia and bleeding, and ensure the timeliness and effectiveness of clinical platelet treatment.
-
Key words:
- platelets /
- RhD type /
- incompatible blood transfusion
-
-
表 1 17例RhD阴性的患者输注单采血小板基本情况
治疗量 血型 RhD(+) RhD(-) 合计 A 5 1 6 B 11 0 11 O 30 1 31 AB 3 0 3 合计 49 2 51 
下载: 导出CSV
-
[1] Valsami S, Dimitroulis D, Gialeraki A, et al. Current trends in platelet transfusions practice: The role of ABO-RhD and human leukocyte antigen incompatibility[J]. Asian J Transfus Sci, 2015, 9(2): 117-123. doi: 10.4103/0973-6247.162684
[2] Moncharmont P. Red blood cell alloimmunisation after platelet transfusion(excluding ABO blood group system)[J]. Transfus Clin Biol, 2020, 27(3): 185-190. doi: 10.1016/j.tracli.2020.06.001
[3] 周静宇. 全血及成分血质量要求(GB18469—2012)实施探讨[J]. 临床血液学杂志, 2013, 26(8): 572-573. https://www.cnki.com.cn/Article/CJFDTOTAL-LCXZ201308030.htm
[4] Poston JN, Sugalski J, Gernsheimer TB, et al. Mitigation strategies for anti-D alloimmunization by platelet transfusion in haematopoietic stem cell transplant patients: a survey of NCCN® centres[J]. Vox Sang, 2020, 115(4): 334-338. doi: 10.1111/vox.12899
[5] Cid J, Lozano M, Ziman A, et al. Low frequency of anti-D alloimmunization following D+ platelet transfusion: the Anti-D Alloimmunization after D-incompatible Platelet Transfusions(ADAPT)study[J]. Br J Haematol, 2015, 168(4): 598-603. doi: 10.1111/bjh.13158
[6] 李菲, 陈伟, 李慧君, 等. 新疆RhD阴性及其表型特点调查分析[J]. 临床血液学杂志, 2020, 33(2): 126-129. https://www.cnki.com.cn/Article/CJFDTOTAL-LCXZ202002014.htm
[7] 中国医师协会输血科医师分会, 中华医学会临床输血学分会. 特殊情况紧急抢救输血推荐方案[J]. 中国输血杂志, 2014, 27(1): 1-3. https://www.cnki.com.cn/Article/CJFDTOTAL-BLOO201401003.htm
[8] Reckhaus J, Jutzi M, Fontana S, et al. Platelet Transfusion Induces Alloimmunization to D and Non-D Rhesus Antigens[J]. Transfus Med Hemother, 2018, 45(3): 167-172. doi: 10.1159/000490122
[9] 李晨越, 陈思恬, 何芮, 等. RhD主动免疫安全性研究[J]. 中国输血杂志, 2021, 34(5): 489-493. https://www.cnki.com.cn/Article/CJFDTOTAL-BLOO202105017.htm
[10] Yazer MH, Triulzi DJ, Sperry JL, et al. Rate of RhD-alloimmunization after the transfusion of multiple RhD-positive primary red blood cell-containing products[J]. Transfusion, 2021, 61(Suppl 1): S150-S158.
[11] Thibault L, de Grandmont MJ, Cayer MP, et al. Rhesus D Antigenic Determinants on Residual Red Blood Cells in Apheresis and Buffy Coat Platelet Concentrates[J]. Transfus Med Hemother, 2020, 47(2): 129-134. doi: 10.1159/000501106
[12] 杨帆, 韩瑜, 聂婷婷, 等. "亚洲型"DEL血型检测方法的比较研究[J]. 中国实验诊断学, 2021, 25(12): 1808-1809. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSZD202112018.htm
[13] Villalba A, Santiago M, Freiria C, et al. Anti-D Alloimmunization after RhD-Positive Platelet Transfusion in RhD-Negative Women under 55 Years Diagnosed with Acute Leukemia: Results of a Retrospective Study[J]. Transfus Med Hemother, 2018, 45(3): 162-166.
-